To examine the role of AhR even more rigorously in triple-negative breast cancer, future studies should determine the effect of deleting AhR, or the effect of AhR alleles with reduced activity [143] in a genetically engineered mouse model (GEMM) of triple-negative breast cancer [153,154]. The gene discussed is AHR; the disease is triple-negative breast carcinoma.